Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures: A Systematic Review and Network Meta-Analysis

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2024 Sep 6

PMID 39240564

Authors

Assil-Ramin Alimy

Athanasios D Anastasilakis

John J Carey

Stella DOronzo

Anda M Naciu

Julien Paccou

Maria P Yavropoulou

Willem F Lems

Tim Rolvien

Affiliations

Soon will be listed here.

Abstract

Importance: Osteoporotic vertebral compression fractures (VCFs) frequently cause substantial pain and reduced mobility, posing a major health problem. Despite the critical need for effective pain management to restore functionality and improve patient outcomes, the value of various conservative treatments for acute VCF has not been systematically investigated.

Objective: To assess and compare different conservative treatment options in managing acute pain related to VCF.

Data Sources: On May 16, 2023, 4 databases-PubMed, Embase, Scopus, and CINAHL-were searched. In addition, a gray literature search within Scopus and Embase was also conducted.

Study Selection: Included studies were prospective comparative and randomized clinical trials that assessed conservative treatments for acute VCF.

Data Extraction And Synthesis: Data extraction and synthesis were performed by 2 authors according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Network Meta-Analyses recommendations. A frequentist graph-theoretical model and a random-effects model were applied for the meta-analysis.

Main Outcomes And Measures: Primary outcomes were short-term (4 weeks) pain during activity and long-term (latest available follow-up) nonspecified pain in patients with acute VCF.

Results: The study included 20 trials, encompassing 2102 patients, and evaluated various interventions for managing VCF. Calcitonin (standardized mean difference [SMD], -4.86; 95% CI, -6.87 to -2.86) and nonsteroidal anti-inflammatory drugs (NSAIDs; SMD, -3.94; 95% CI, -7.30 to -0.58) were beneficial regarding short-term pain during activity compared with placebo. For long-term nonspecific pain management, bisphosphonates were associated with inferior pain outcomes compared with daily (SMD, 1.21; 95% CI, 0.11 to 2.31) or weekly (SMD, 1.13; 95% CI, 0.05 to 2.21) administration of teriparatide, with no treatment being superior to NSAIDs. The qualitative analysis of adverse events highlighted that typical adverse events associated with these medications were observed.

Conclusions And Relevance: NSAIDs and teriparatide may be the preferred treatment options for pain management in acute osteoporotic VCF. Although calcitonin also proved to be beneficial, its safety profile and potential adverse effects restrict its widespread application. The limited evidence on braces and analgesics underscores the urgent need for future research.

Citing Articles

Safety and feasibility of a smart assistive bone-cement injection system: a cadaveric study.

Jin C, Ning M, Xu R, Ye X, Chen H, Yu J J Orthop Surg Res. 2025; 20(1):272.

PMID: 40075404 PMC: 11905486. DOI: 10.1186/s13018-025-05680-9.

Minimally Invasive Surgical Approach in Granulomatosis with Polyangiitis Complicated with Intramural Descending Aorta Hematoma Followed by Aortic Wall Rupture.

Ciobica M, Botezatu A, Galajda Z, Carsote M, Nistor C, Sandulescu B Diagnostics (Basel). 2025; 15(2).

PMID: 39857028 PMC: 11763346. DOI: 10.3390/diagnostics15020144.

References

Chen P, Miller P, Delmas P, Misurski D, Krege J . Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res. 2006; 21(11):1785-90. DOI: 10.1359/jbmr.060802. View

Barr J, Jensen M, Hirsch J, McGraw J, Barr R, Brook A . Position statement on percutaneous vertebral augmentation: a consensus statement developed by the Society of Interventional Radiology (SIR), American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS),.... J Vasc Interv Radiol. 2013; 25(2):171-81. DOI: 10.1016/j.jvir.2013.10.001. View

Genant H, Jergas M, Palermo L, Nevitt M, Valentin R, Black D . Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996; 11(7):984-96. DOI: 10.1002/jbmr.5650110716. View

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

Dias S, Welton N, Caldwell D, Ades A . Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010; 29(7-8):932-44. DOI: 10.1002/sim.3767. View

Wardlaw D, Cummings S, Van Meirhaeghe J, Bastian L, Tillman J, Ranstam J . Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009; 373(9668):1016-24. DOI: 10.1016/S0140-6736(09)60010-6. View

Shigenobu K, Hashimoto T, Kanayama M, Ohha H, Yamane S . The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing - In comparison with weekly teriparatide with bisphosphonate. Bone Rep. 2019; 11:100217. PMC: 6700423. DOI: 10.1016/j.bonr.2019.100217. View

Kim H, Yi J, Cho H, Chang B, Lee C, Kim J . Comparative study of the treatment outcomes of osteoporotic compression fractures without neurologic injury using a rigid brace, a soft brace, and no brace: a prospective randomized controlled non-inferiority trial. J Bone Joint Surg Am. 2014; 96(23):1959-66. DOI: 10.2106/JBJS.N.00187. View

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

10.

Hoshino M, Tsujio T, Terai H, Namikawa T, Kato M, Matsumura A . Impact of initial conservative treatment interventions on the outcomes of patients with osteoporotic vertebral fractures. Spine (Phila Pa 1976). 2013; 38(11):E641-8. DOI: 10.1097/BRS.0b013e31828ced9d. View

11.

Nair V, Kundnani V, Shetty A, Anand M, Jain M, Dewnany N . Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis. Asian Spine J. 2023; 17(6):1098-1107. PMC: 10764133. DOI: 10.31616/asj.2023.0109. View

12.

Klazen C, Lohle P, de Vries J, Jansen F, Tielbeek A, Blonk M . Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet. 2010; 376(9746):1085-92. DOI: 10.1016/S0140-6736(10)60954-3. View

13.

Endo N, Fujino K, Doi T, Akai M, Hoshino Y, Nakano T . Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial. J Bone Miner Metab. 2016; 35(4):375-384. DOI: 10.1007/s00774-016-0765-8. View

14.

Tsuchie H, Miyakoshi N, Kasukawa Y, Nishi T, Abe H, Segawa T . The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab. 2015; 34(1):86-91. DOI: 10.1007/s00774-014-0646-y. View

15.

Ikeda S, Nakamura E, Narusawa K, Fukuda F, Matsumoto H, Nakai K . Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12. J Bone Miner Metab. 2019; 38(1):44-53. DOI: 10.1007/s00774-019-01023-x. View

16.

Cummings S, Santora A, Black D, Russell R . History of alendronate. Bone. 2020; 137:115411. DOI: 10.1016/j.bone.2020.115411. View

17.

Prather H, Hunt D, Watson J, Gilula L . Conservative care for patients with osteoporotic vertebral compression fractures. Phys Med Rehabil Clin N Am. 2007; 18(3):577-91, xi. DOI: 10.1016/j.pmr.2007.05.008. View

18.

Anastasilakis A, Makras P, Paccou J, Bisbinas I, Polyzos S, Papapoulos S . Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab. J Clin Med. 2023; 12(18). PMC: 10532339. DOI: 10.3390/jcm12185874. View

19.

Shaladi A, Saltari M, Piva B, Crestani F, Tartari S, Pinato P . Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Clin J Pain. 2007; 23(6):511-7. DOI: 10.1097/AJP.0b013e31806a23d4. View

20.

Choi J, Kang H, Park J, Gu B, Jung S, Oh S . The Efficacy of Fentanyl Transdermal Patch as the First-Line Medicine for the Conservative Treatment of Osteoporotic Compression Fracture. Korean J Neurotrauma. 2017; 13(2):130-136. PMC: 5702748. DOI: 10.13004/kjnt.2017.13.2.130. View